2-hydroxyheneicosanoic acid | 93361-62-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-hydroxyheneicosanoic acid
• 英文别名: α-Hydroxy-heneicosansaeure；1-Oxy-eikosan-carbonsaeure-(1)；2-Hydroxy-heneicosansaeure；2-Hydroxyhenicosanoic acid
• CAS: 93361-62-7
• 化学式: C₂₁H₄₂O₃
• 分子量: 342.563
• InChiKey: DHCJPXKWDPRJAX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.1
• 重原子数：
  24
• 可旋转键数：
  19
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-hydroxyheneicosanoic acid 生成 alkaline earth salt of/the/ methylsulfuric acid
  参考文献：
  名称：

  Le Sueur; Withers, Journal of the Chemical Society, 1915, vol. 107, p. 737

  摘要：

  DOI：
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 氢氧化钾 作用下， 生成 2-hydroxyheneicosanoic acid
  参考文献：
  名称：

  Le Sueur; Withers, Journal of the Chemical Society, 1915, vol. 107, p. 737

  摘要：

  DOI：

文献信息

• Lipids That Increase Insulin Sensitivity And Methods Of Using The Same
  申请人：BETH ISRAEL DEACONESS MEDICAL CENTER, INC.

  公开号：US20160221925A1

  公开（公告）日：2016-08-04

  The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders—including diabetes-related disorders, Metabolic Syndrome, polycystic ovarian syndrome, cancer, and inflammatory disorders—using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.

  该发明提供了脂肪酰羟基脂肪酸（FAHFA；一类新型的酯脂类分子）以及用于诊断和治疗各种疾病的方法，包括与糖尿病相关的疾病、代谢综合征、多囊卵巢综合征、癌症和炎症性疾病等；以及筛选可用于治疗这些疾病和/或调节FAHFA水平、FAHFA介导信号传导和FAHFA介导生物效应的其他化合物的方法。
• [EN] LIPIDS THAT INCREASE INSULIN SENSITIVITY AND METHODS OF USING THE SAME<br/>[FR] LIPIDES AUGMENTANT LA SENSIBILITÉ À L'INSULINE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：BETH ISREAL DEACONESS MEDICAL CT INC

  公开号：WO2013166431A1

  公开（公告）日：2013-11-07

  The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders- including diabetes-related disorders, Metabolic Syndrome, polycyctic ovarian syndrome, cancer, and inflammatory disorders— using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.

  这项发明提供了脂肪酰羟基脂肪酸（FAHFA；一类新型的酯脂类分子）以及用于治疗各种疾病的诊断和治疗方法，包括与糖尿病相关的疾病、代谢综合征、多囊卵巢综合征、癌症和炎症性疾病，以及使用它们的方法；以及筛选对这些疾病有用或调节FAHFA水平、FAHFA介导的信号传导和FAHFA介导的生物效应的其他化合物的方法。
• [EN] LIPID PRODRUGS OF CELECOXIB AND USES THEREOF<br/>[FR] PROMÉDICAMENTS LIPIDIQUES DE CÉLÉCOXIB ET LEURS UTILISATIONS
  申请人：UNIV MONASH

  公开号：WO2021051172A1

  公开（公告）日：2021-03-25

  The present invention provides methods of treating metabolic diseases including obesity, insulin resistance and type 2 diabetes with inhibitors of COX-2 or VEGFR and lipid prodrugs of COX-2 inhibitors, in particular celecoxib lipid prodrugs, that promote transport of the pharmaceutical agent to the lymphatic system and which enhance release of the parent agent.

  本发明提供了一种治疗代谢性疾病，包括肥胖、胰岛素抵抗和2型糖尿病的方法，使用COX-2或VEGFR的抑制剂以及COX-2抑制剂的脂质前药，特别是促进药物剂运送到淋巴系统并增强母药释放的Celecoxib脂质前药。
• COMPOSITIONS COMPRISING POLYMERS PREPARED FROM 2-HYDROXYALKYL ACIDS
  申请人：Moeller Michael

  公开号：US20130131190A1

  公开（公告）日：2013-05-23

  Described herein are compositions comprising polymers prepared by melt polycondensation of 2-hydroxyalkyl acids. Methods of making and using the compositions are also disclosed.

  本文描述了由2-羟基烷基酸熔融缩聚制备的聚合物组成物。还公开了制备和使用该组成物的方法。
• Process for preparing fatty acid esters
  申请人：NIPPON FINE CHEMICAL CO., LTD.

  公开号：EP0195311A2

  公开（公告）日：1986-09-24

  A process for reacting (1) a component selected from the group consisting of sterols and branched aliphatic primary or secondary alcohols having 14 to 32 carbon atoms, and (2) a component selected from the group consisting of fatty acids and fatty acid esters in contact with an enzyme selected from the group consisting of lipase and cholesterol esterase or with the selected enzyme in an immobilized form, in a system selected from the group consisting of an aqueous medium and water-containing organic solvent to prepare a fatty acid ester of the component (1).

  一种工艺，用于在水介质和含水有机溶剂组成的体系中，使(1)选自固醇和具有 14 至 32 个碳原子的支链脂肪族伯醇或仲醇组成的组中的一种组分，和(2)选自脂肪酸和脂肪酸酯组成的组中的一种组分，与选自脂肪酶和胆固醇酯化酶组成的组中的一种酶接触，或以固定形式与所选的酶接触，以制备组分(1)的脂肪酸酯。